Explore
Upload

DocSlides is a free service to upload presentations and documents.

Upload Now

Search Results for 'Cml Imatinib'

Cml Imatinib published presentations and documents on DocSlides.

Chronic

Chronic

  • briana-ranney
  • 61 Slides

M. yeloid Leukemia. Amer Rassam, M.D.. Learning O...

OHSU Updates in Hematology

OHSU Updates in Hematology

  • calandra-battersby
  • 50 Slides

and. Breast Cancer Conference. CML . ASH Update. ...

Imatinib

Imatinib

  • phoebe-click
  • 37 Slides

Resistance. Geoffrey L. Uy, M.D.. Associate Prof...

Clinical Considerations in

Clinical Considerations in

  • faustina-dinatale
  • 57 Slides

Evidence-based Management . of GIST. Program Goal...

Gastrointestinal Stromal Tumors

Gastrointestinal Stromal Tumors

  • tawny-fly
  • 30 Slides

Definition of Gastrointestinal Stromal Tumor . th...

Impact of Imatinib interruption & duration of prior Hyd

Impact of Imatinib interruption & duration of prior Hyd

  • pamella-moone
  • 21 Slides

Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof ...

Anticancer Therapy:

Anticancer Therapy:

  • stefany-barnette
  • 23 Slides

Kinase. Inhibitors. Charles Harrell. Outline of ...

Philadephia

Philadephia

  • danika-pritchard
  • 53 Slides

chromosomal positive acute lymphoblastic leukemi...

ETV1 is a lineage survival factor that cooperates with KIT

ETV1 is a lineage survival factor that cooperates with KIT

  • test
  • 16 Slides

stromal. tumors. Introduction. Tim Butler. March...

Prof Giovanni Brandi

Prof Giovanni Brandi

  • liane-varnes
  • 34 Slides

. University. of Bologna . Advances. in . c...

Modeling Imatinib-Treated Chronic Myeloid Leukemia

Modeling Imatinib-Treated Chronic Myeloid Leukemia

  • phoebe-click
  • 14 Slides

Cara Peters. cpeters3@math.umd.edu. Advisor: Dr. ...

Jon Trent, MD, PhD Professor of Medicine

Jon Trent, MD, PhD Professor of Medicine

  • jane-oiler
  • 0 Slides

Sarcoma . Medical Oncology. The University of . M...

Imatinib Resistance Geoffrey L. Uy, M.D.

Imatinib Resistance Geoffrey L. Uy, M.D.

  • karlyn-bohler
  • 0 Slides

Associate Professor . of Medicine. Division of On...

ADVANCES IN THERAPY FOR SARCOMA AND GIST

ADVANCES IN THERAPY FOR SARCOMA AND GIST

  • ellena-manuel
  • 0 Slides

Angela . Cioffi. , MD. Sarcoma Research Program c...

GREETING BUENOS DÍAS GOOD MORNING

GREETING BUENOS DÍAS GOOD MORNING

  • escapistlego
  • 43 Slides

BONJOUR. Tolerance of . Imatinib. . Dasatinib. ...

Chronic M yeloid Leukemia

Chronic M yeloid Leukemia

  • eliza
  • 61 Slides

Amer Rassam, M.D.. Learning Objectives. Myeloproli...

La LAL del adulto tiene mal pronóstico

La LAL del adulto tiene mal pronóstico

  • walsh
  • 35 Slides

PETHEMA LAL infantil. PETHEMA LAL Adulto. 15%. 25%...

Overview of CML & Recent Advances

Overview of CML & Recent Advances

  • stella
  • 131 Slides

I. ntroduction. CML is a clonal myeloproliferative...

Impact of Imatinib interruption & duration of prior Hydroxyurea on treatment outcome in CML pat

Impact of Imatinib interruption & duration of prior Hydroxyurea on treatment outcome in CML pat

  • hadly
  • 17 Slides

Raafat. R. Abdel-. Malek. , MD, FRCR. Ass. Prof C...

S1 TableRisk classification according to Armed Forces Institute of Pa

S1 TableRisk classification according to Armed Forces Institute of Pa

  • finley
  • 1 Slides

A FIP risk criteria 3 ears of imatinib (n= 31) 5 Y...

Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE

Proceedings of UCLA HealthVOLUME 22201CLINICAL VIGNETTE

  • tracy
  • 3 Slides

Dermatofibrosarcoma protuberans Fukai Leo Chuang, ...

SCIENTIFIC DISCUSSION 1 Introduction The scope of this Type II varia

SCIENTIFIC DISCUSSION 1 Introduction The scope of this Type II varia

  • evelyn
  • 14 Slides

Metastasis of DFSP is rare, occurring in approxima...

Treatment of Imatinib -resistant GIST

Treatment of Imatinib -resistant GIST

  • beatrice
  • 46 Slides

: . The Next Generation. Dr. Michael Heinrich, M....

Copyright © 2024 DocSlides. All Rights Reserved